14064-12-1

Upstream product

• 14064-13-2 (1-methylcyclohexyl)methanol 
• 98-59-9 p-toluenesulfonyl chloride 
• 825-04-7 methyl 1-methylcyclohexanecarboxylate 
• 4630-82-4 methyl cyclohexylcarboxylate 
• 98-89-5 Cyclohexanecarboxylic acid 
• 1123-25-7 1-methyl-1-cyclohexanecarboxylic acid 

Downstream Products

• 1035947-92-2 C₁₇H₂₀O₃ 
• 1360568-83-7 4-bromo-1-chloro-2-(4-((1-methylcyclohexyl)methoxy)benzyl)benzene 
• 1360568-84-8 (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-((1-methylcyclohexyl)methoxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol 
• 138476-36-5 diethyl 4-[((1-methyl)cyclohexyl)methoxy]benzylphosphonate 
• 317332-23-3 1-furan-3-yl-2-(1-methyl-cyclohexyl)-ethanol 

Relevant academic research and scientific papers

3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

Provided are cinnolinyl and quinolinyl pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor, compositions comprising said compounds, and uses of said compounds in the treatment or prevention of diseases in which M4 muscarinic acetylcholine receptors are involved, especially neurological and psychiatric disorders and diseases.

CYCLOALKYL METHOXYBENZYL PHENYL PYRAN DERIVATIVES AS SODIUM DEPENDENT GLUCOSE CO TRANSPORTER (SGLT2) INHIBITORS

The invention relates to the cycloalkyl methoxybenzyl phenyl pyran derivatives as Sodium dependent glucose co transporter (SGLT) inhibitors, particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGLT2 with them, and processes for preparing them.

Synthesis of the novel analogues of dysidiolide and their structure-activity relationship

The novel analogues of natural cdc25A inhibitor dysidiolide were synthesized. To investigate the structure-activity relationship, the inhibitory activity to enzyme and cell cycle was examined. (C) 2000 Elsevier Science Ltd.